Chris Cleary - 23 Jun 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: Director
Issuer ticker: OBIO
Reported as of: 23 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2026, 16:19:38 UTC
Prior SEC filing: 06 Feb 2026
Next SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

Chris Cleary filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 25 Jun 2026.

Key facts

This page summarizes Chris Cleary's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2026, 16:19.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002054585 Primary reporting owner

Cleary Chris

Relationship: Director
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock, par value $0.0001 per share

Tax liability

Transaction value
Shares: -3,510
Change %: -9.5%
Price: $0.000000^*
Shares after: 33,391
Date: 24 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OBIO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +42,553
Change %
Price: $0.000000^*
Shares after: 42,553
Date: 23 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 42,553
Exercise price: $4.04
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Footnote F2

The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.